MedTrace Logo

Enhanced Tuberculosis Case Detection Among Substitution Treatment Patients

NCT01290081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 112

Last updated 2011-02-04

No results posted yet for this study

Summary

The purpose of this study was to determine the prevalence of latent tuberculosis infection among injecting drug users and to conduct randomized controlled trial to evaluate a case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program in Estonia.

Conditions

Interventions

OTHER

Case management approach in referral to health care services

Case management intervention aimed at increasing TB screening and treatment entry among injecting drug users referred from a methadone drug treatment program

Sponsors & Collaborators

  • LLC Corrigo

    collaborator UNKNOWN

  • Ida-Viru Central Hospital, Department of Tuberculosis

    collaborator UNKNOWN

  • National Institute for Health Development, Estonia

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Estonia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01290081 on ClinicalTrials.gov